Alcolase

Biotech · Copenhagen, DK

Enzyme-based technology that breaks down alcohol in the stomach, targeting ALDH2 deficiency common in East Asia.

In the network

Shares the most investors with (number = shared investors):

Create a free EquityFlow account to see Alcolase's 1 funding round, 4 investors, 12 similar companies.